Related Experiment Video
Updated: Aug 30, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma
Sitansu S Nanda1, Md Imran Hossain1, Heongkyu Ju2
1Department of Chemistry, Myongji University, Yongin, 03674, South Korea.
Abstract:
The author requested to add a co-author after the publication of the original article [1]. In this correction, the author has been added in the article entitled "GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma" in the journal "Current Drug Targets" 2021; 22(13), 1485-1495. Details of the error and a correction are provided here. The original editorial can be found online at 10.2174/1389450122666210204203950 We regret any errors and apologize to the readers. Original: Sitansu S. Nanda1, Md Imran Hossain1, Heongkyu Ju2 and Dong Kee Yi1,* 1Department of Chemistry, Myongji University, Yongin, 03674, South Korea; 2Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea Corrected: Sitansu S. Nanda1, Md Imran Hossain1, Heongkyu Ju2, Georgia C. Papaefthymiou3 and Dong Kee Yi1,* 1Department of Chemistry, Myongji University, Yongin, 03674, South Korea; 2Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea 3Department of Physics, Villanova University, Villanova, Pennsylvania19085, USA.
Insights
This correction adds Georgia C. Papaefthymiou as a co-author to the article "GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma," published in Current Drug Targets. The update ensures accurate author attribution for the research.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- The original article focused on Glycogen Synthase Kinase 3 (GSK-3) inhibitors.
- Colon carcinoma is a significant area of cancer research.
Purpose of the Study:
- To correct the author list of a previously published article.
- To include Georgia C. Papaefthymiou as a co-author.
Main Methods:
- Correction of author information in a published scientific article.
- Ensuring accurate citation and attribution.
Main Results:
- Georgia C. Papaefthymiou has been officially added as a co-author.
- The corrected author list is now reflected in the article.
Conclusions:
- Accurate author attribution is crucial for scientific integrity.
- This correction ensures proper credit for all contributors to the research on GSK-3 inhibitors and colon carcinoma.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
GPCRs Regulate Adenylyl Cylase Activity
GTPases and their Regulation

